This document is an extract of the consolidated and standalone financial results for Tatva Chintan Pharma Chem Limited for the quarter ended June 30, 2026.Total income from operations for the quarter was 1,670.55 million INR.Net profit for the period (after tax) was reported at 159.81 million INR.The results were reviewed by the Audit Committee and approved by the Board of Directors on July 17, 2026.